Current Status, Challenges and Future of Precision Medicine for Colorectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 1 October 2024 | Viewed by 136
Special Issue Editors
Interests: pathogenesis of HPB cancers; surgical innovation; organ preservation; machine perfusion; US histotripsy; irreversible electroporation (IRE); evidence based healthcare
Interests: innovations in management of stage 4 colorectal cancer; locally advanced colorectal cancer; recurrent rectal cancer; peritoneal cancer; anal cancer
Interests: colorectal cancer; anal cancer; bile duct cancer (cholangiocarcinoma); biliary cancer; cancer of unknown primary; colon cancer; gastrointestinal cancers; medical oncology; small bowel cancer liquid biopsies; tumour heterogeneity; patient-derived organoids; bioinformatics; next generation sequencing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Precision medicine or personalized medicine is a rapidly evolving approach in colorectal cancer treatment in which therapy is tailored to individual patients based on the integration of data onthe disease characteristics on imaging, the histological phenotype of the cancer, the cancer genomic and proteomic profiles, the natural history of the disease progression and the response patterns to treatment. Increasingly this complex integration of information is used to anticipate treatment responses and the optimization of therapy.
This special issue aims to provide a comprehensive overview of the current status, challenges, and future prospects of precision medicine in colorectal cancer. It explores the molecular classification of colorectal cancer and highlights the recent advancements in targeted therapies, immunotherapies, and liquid biopsies. The impact of this molecular information and immunological treatment on surgical management of primary and metastatic disease will be reviewed including controversial areas such as synchronous bowel and liver resection and liver transplant for colorectal cancer.
We will explore the potential of next-generation sequencing, radiomics, artificial intelligence and machine learning to improve the diagnosis, prognosis and monitoring of CRC patients. We hope that this special issue will provide a comprehensive and updated overview of precision medicine for CRC and stimulate further research and innovation in this field. We look forward to receiving your contributions.
Prof. Dr. Brian Davidson
Prof. Dr. Jamie Murphy
Dr. Khurum Khan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- precision medicine
- personalised medicine
- synchronous resection
- downstaging
- liver transplant
- molecular profiling
- biomarkers
- radiomics
- targeted therapy
- immunotherapy
- liquid biopsy
- next-generation sequencing
- machine learning
- artificial intelligence
